Martine Kruijtbosch

199 Gene ra l d i s cu s s i on 75. Bos E JJ. ‘Onderhandelingspositie van apothekers verslechterd door basiscontract’ karik van berloo: Verschuiving matchtsbalans bij contractering. Pharm Weekbl 2021;4. 76. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care . Am J Hosp Pharm 1990;47:533-543. 77. Stichting Farmaceutocshe Kengetallen (SFK). Voorschrijfreden meest vastgelegd bij fluconazol. Inkijkje in vastgelegde redenen van voorschrijven. Pharm Weekbl 2017;50. 78. Garada M, McLachlan AJ, Schiff GD, Lehnbom EC. What do Australian consumers, pharmacists and prescribers think about documenting indications on prescriptions and dispensed medicines labels?: A qualitative study. BMC Health Serv Res 2017;17:734-742. 79. Kron K, Myers S, Volk L, Nathan A, Neri P, Salazar A, et al. Incorporating medication indications into the prescribing process. Am J Health Syst Pharm 2018;75:774-783. 80. KNMP-procedure development guidelines for the community pharmacist. 2018. https://www. knmp.nl/downloads/procedure-knmp-richtlijnen.pdf/at_download/file. Accessed 23 April 2021. 81. Austin Z, Gregory PAM, Martin JC. Characterizing the professional relationships of community pharmacists. Res Social Adm Pharm 2006;2:533-546. 82. Thoma SJ, Bebeau MJ. Moral motivation and the four component model. In: Handbook of moral motivation. Rotterdam: Sense Publishers 2013:49-67. 83. Stephens JM. Bridging the divide: The role of motivation and self-regulation in explaining the judgment-action gap related to academic dishonesty. Front Psychol 2018;9:246. 84. Russ J. Ethical decisions: A phenomenological qualitative study examining pharmacists dispensing opioids during an opioid crisis. 2019. La Jolla, California: Northcentral University. https://www. proquest.com/openview/af4454b8ba4ff869973336b7e02d4245/1?pq-origsite=gscholar&cbl=519 22&diss=y. Accessed 15 may 2021. 85. BebeauMJ, Rest JR, Narvaez D. Beyond the promise: A perspective on research inmoral education. Educ Res 1999;28:18-26. 86. Cruess R, Cruess S, Steinert Y. Amending miller’s pyramid to include professional identity formation. Acad Med 2016;91:180-185. 87. Bebeau MJ, Monson VE. Professional identity formation and transformation across the life span. In: Learning trajectories, innovation and identity for professional development. Dordrecht: Springer Netherlands; 2011:135-162. 88. Myyry L. Components of morality: A professional ethics perspective on moral motivation, moral sensitivity, moral reasoning and related constructs among university students. 2003. Helsinki: University of Helsinki. 89. Muijrers P. Changing relationships: Attitudes and opinions of general practitioners and pharmacists regarding the role of the community pharmacist. Pharm World Sci 2003;25:235241. 90. Mossialos E, Courtin E, Naci H, Benrimoj S, Bouvy M, Farris K, et al. From "retailers" to health care providers: Transforming the role of community pharmacists in chronic disease management . Health Policy 2015;119:628-639. 91. Florentinus SR, van Hulten R, Kramer M, van Dijk L, Heerdink ER, Leufkens HG, et al. Which pharmacists contribute to high-level pharmacotherapy audit meetings with general practitioners? Ann Pharmacother 2006;40:1640-1646.